Omission of axillary lymph node dissection in breast cancer patients with micrometastasis or isolated tumor cells in sentinel lymph nodes: a 12-year experience in a tertiary breast unit.
Nuno SousaBárbara PeleteiroJosé Luis FougoPublished in: Journal of cancer research and clinical oncology (2023)
Avoiding ALND may be safe in pN1mi/pN0(i+) patients. Besides, we strongly encourage clinicians to develop their own follow-up protocols based on the best available evidence, to rapidly identify and treat breast cancer recurrence.
Keyphrases
- lymph node
- end stage renal disease
- sentinel lymph node
- chronic kidney disease
- newly diagnosed
- ejection fraction
- neoadjuvant chemotherapy
- peritoneal dialysis
- prognostic factors
- prostate cancer
- palliative care
- early stage
- patient reported outcomes
- radical prostatectomy
- ultrasound guided
- robot assisted
- patient reported